CS logo
small CS logo
Hôpital Ambroise Paré - Pneumologie

Boulogne, France
Hôpital à Boulogne-Billancourt

About Hôpital Ambroise Paré - Pneumologie


Les hôpitaux Ambroise Paré et Paul Desbief sont les établissements fondateurs de l'Hôpital européen de Marseille. Établissement de santé non lucratif, la Fondation Hôpital Ambroise Paré a été reconnue d’utilité publique en 1875.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Hôpital Ambroise Paré - Pneumologie


During the past decade, Hôpital Ambroise Paré - Pneumologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Ambroise Paré - Pneumologie" #1 collaborator was "Groupe Francais De Pneumo-Cancerologie" with 2 trials as a collaborator and "University Hospital, Caen" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at Hôpital Ambroise Paré - Pneumologie


According to Clinical.Site data, the most researched conditions in "Hôpital Ambroise Paré - Pneumologie" are "ALK Gene Mutation" (1 trials), "Advanced Non Small Cell Lung Cancer" (1 trials), "BRAF Gene Mutation" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "KRAS Gene Mutation" (1 trials). Many other conditions were trialed in "Hôpital Ambroise Paré - Pneumologie" in a lesser frequency.

Clinical Trials Intervention Types at Hôpital Ambroise Paré - Pneumologie


Most popular intervention types in "Hôpital Ambroise Paré - Pneumologie" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Cisplatin" (1 trials), "Durvalumab" (1 trials), "Erlotinib" (1 trials), "Fulvestrant" (1 trials) and "Gefitinib" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Hôpital Ambroise Paré - Pneumologie


The vast majority of trials in "Hôpital Ambroise Paré - Pneumologie" are 5 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Hôpital Ambroise Paré - Pneumologie


Currently, there are NaN active trials in "Hôpital Ambroise Paré - Pneumologie". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Hôpital Ambroise Paré - Pneumologie, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hôpital Ambroise Paré - Pneumologie, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".